Abstract
Microfluidic systems have become an attractive platform for diagnostic applications. The technology not only allows drastically decreased assay volumes (down to picoliters), but also accelerates sample processing and readout. In this article we give an overview of the different kinds of systems, ranging from non- or minimally instrumented point-of-care devices for the detection of pathogens to fully-instrumented cutting-edge technologies such as next-generation sequencing and droplet-based microfluidics. We expect that microfluidic systems will have a major impact on future diagnostic (e.g., disposable devices) and therapeutic approaches (e.g., personalized medicine). Here we summarize current trends and critically review the limitations.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.